X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-09-16 | BBNX | Beta Bionics, Inc. | Hopman Mark | Chief Commercial Officer | S - Sale | $20.13 | -30,779 | 56,479 | -35% | -$619,640 | ||||||
2026-09-16 | BBNX | Beta Bionics, Inc. | Mensinger Mike | Chief Product Officer | S - Sale | $22.00 | -2,650 | 177,390 | -1% | -$58,300 | ||||||
| M | 2026-09-14 | TELA | Tela Bio, Inc. | Capper Joseph H | Dir | P - Purchase | $1.05 | +75,000 | 104,827 | +251% | +$78,443 | |||||
2026-09-15 | CTSO | Cytosorbents Corp | Chan Phillip P. | CEO | P - Purchase | $6.00 | +3,774 | 100,996 | +4% | +$22,644 | ||||||
| D | 2026-09-15 | GMED | Globus Medical Inc | Tobin James R | Dir | S - Sale+OE | $74.58 | -30,000 | 0 | -100% | -$2,237,502 | |||||
| M | 2026-09-14 | DXCM | Dexcom Inc | Augustinos Nicholas | Dir | S - Sale | $84.04 | -8,089 | 34,868 | -19% | -$679,769 | |||||
2026-09-15 | DXCM | Dexcom Inc | Brown Michael Jon | EVP Chief Legal Compliance Off | S - Sale | $84.04 | -1,700 | 99,885 | -2% | -$142,868 | ||||||
2026-09-14 | CTSO | Cytosorbents Corp | Capponi Vincent | Pres, COO | P - Purchase | $6.05 | +2,073 | 40,387 | +5% | +$12,537 | ||||||
2026-09-15 | CTSO | Cytosorbents Corp | Sobel Alan D. | Dir | P - Purchase | $6.10 | +2,500 | 9,887 | +34% | +$15,254 | ||||||
2026-09-14 | GUTS | Fractyl Health, Inc. | Bradley William | Dir | P - Purchase | $0.62 | +64,516 | 149,138 | +76% | +$39,903 | ||||||
2026-09-16 | RDGL | Vivos Inc | Weeks Brad Allan | Pres | P - Purchase | $0.05 | +25,550 | 1,547,204 | +2% | +$1,232 | ||||||
| M | 2026-09-11 | HTFL | Heartflow, Inc. | Verghese Vikram | CFO | S - Sale | $50.08 | -34,975 | 179,528 | -16% | -$1,751,611 | |||||
| A | 2025-07-24 | CARL | Carlsmed, Inc. | Presidio Management Group Xii, L.L.C. | 10% | P - Purchase | $15.00 | +200,000 | 200,000 | New | +$3,000,000 | |||||
| DM | 2026-09-11 | WST | West Pharmaceutical Services Inc | Favorite Annette F | SVP, CHRO | S - Sale+OE | $355.03 | -7,524 | 21,818 | -26% | -$2,671,260 | |||||
2026-09-11 | MOBI | Mobia Medical, Inc. | Leavitt Chase C. | See Remarks | P - Purchase | $10.30 | +2,000 | 5,000 | +67% | +$20,600 | ||||||
2026-09-14 | BBNX | Beta Bionics, Inc. | Hopman Mark | Chief Commercial Officer | S - Sale | $15.52 | -775 | 86,382 | -1% | -$12,028 | ||||||
| M | 2026-08-27 | PETV | Petvivo Holdings, Inc. | A.L. Sarroff Fund, LLC | 10% | P - Purchase | $0.68 | +58,602 | 20,960,800 | 0% | +$40,022 | |||||
| D | 2026-09-14 | SI | Shoulder Innovations, Inc. | Ball Robert Joseph | CEO, Exec COB | S - Sale+OE | $18.45 | -10,175 | 380,824 | -3% | -$187,706 | |||||
2026-09-11 | PDEX | Pro Dex Inc | Van Kirk Richard Lee Jr | CEO | S - Sale | $59.36 | -765 | 79,228 | -1% | -$45,412 | ||||||
2026-09-11 | NVNO | Envveno Medical Corp | Duhay Francis | Dir | S - Sale | $11.21 | -11 | 2,351 | 0% | -$123 | ||||||
| M | 2026-09-10 | HTFL | Heartflow, Inc. | Farquhar John C.M. | CEO | S - Sale | $46.78 | -38,900 | 321,914 | -11% | -$1,819,605 | |||||
2026-09-11 | ATRC | Atricure, Inc. | Groves Regina E | Dir | S - Sale | $54.22 | -5,313 | 34,546 | -13% | -$288,071 | ||||||
2026-09-10 | DXCM | Dexcom Inc | Sylvain Jereme M | EVP, Chief Financal Officer | S - Sale | $83.27 | -3,638 | 146,828 | -2% | -$302,936 | ||||||
2026-09-10 | AORT | Artivion, Inc. | Green Andrew M | SVP, Regulatory, Quality | S - Sale | $24.97 | -11,480 | 40,160 | -22% | -$286,656 | ||||||
| M | 2026-09-08 | TNON | Tenon Medical, Inc. | Hrt Financial LP | 10% | P - Purchase | $3.54 | +108,140 | 15,839 | -117% | +$382,985 | |||||
| M | 2026-09-09 | TNON | Tenon Medical, Inc. | Hrt Financial LP | 10% | S - Sale | $4.28 | -125,925 | 15,839 | -89% | -$538,645 | |||||
2026-09-10 | KIDS | Orthopediatrics Corp | Squadron Capital LLC | 10% | S - Sale | $21.01 | -302,369 | 6,201,764 | -5% | -$6,352,773 | ||||||
2026-09-10 | KIDS | Orthopediatrics Corp | Pritzker Jennifer N. | 10% | S - Sale | $21.01 | -302,369 | 6,216,471 | -5% | -$6,352,773 | ||||||
2026-09-10 | ATEC | Alphatec Holdings, Inc. | Miles Patrick | CEO | P - Purchase | $8.81 | +115,000 | 6,154,451 | +2% | +$1,013,150 | ||||||
2026-09-08 | KMTS | Kestra Medical Technologies, Ltd. | Schwartz Jeffrey Lawrence | Dir, 10% | S - Sale | $25.18 | -3,890 | 25,186,574 | 0% | -$97,942 | ||||||
2026-09-08 | KMTS | Kestra Medical Technologies, Ltd. | Hanley Conor | Dir | S - Sale | $25.25 | -5,694 | 13,489 | -30% | -$143,779 | ||||||
2026-09-08 | KMTS | Kestra Medical Technologies, Ltd. | Reilly Kevin C | Dir | S - Sale | $25.13 | -2,932 | 12,585 | -19% | -$73,677 | ||||||
2026-09-08 | KMTS | Kestra Medical Technologies, Ltd. | Ladone Mary Kay | Dir | S - Sale | $25.20 | -3,908 | 44,724 | -8% | -$98,464 | ||||||
2026-09-09 | PDEX | Pro Dex Inc | Van Kirk Richard Lee Jr | CEO | S - Sale | $60.58 | -19,235 | 79,993 | -19% | -$1,165,290 | ||||||
2026-09-09 | PDEX | Pro Dex Inc | Charlton Alisha | CFO | S - Sale | $61.30 | -2,300 | 21,870 | -10% | -$140,983 | ||||||
| D | 2026-09-08 | WST | West Pharmaceutical Services Inc | Favorite Annette F | SVP, CHRO | S - Sale+OE | $340.81 | -8,135 | 16,845 | -33% | -$2,772,489 | |||||
2026-09-08 | HTFL | Heartflow, Inc. | Verghese Vikram | CFO | S - Sale | $50.03 | -6,640 | 214,503 | -3% | -$332,212 | ||||||
2026-09-09 | PRCT | Procept Biorobotics Corp | Nouri Alaleh | EVP, CLO, CORP. SEC. | S - Sale | $20.95 | -297 | 127,737 | 0% | -$6,223 | ||||||
2026-09-09 | PRCT | Procept Biorobotics Corp | Templin Barry L | EVP, CTO | S - Sale | $20.95 | -373 | 94,826 | 0% | -$7,815 | ||||||
2026-09-09 | PRCT | Procept Biorobotics Corp | Waters Kevin | EVP, CFO | S - Sale | $20.95 | -373 | 180,355 | 0% | -$7,815 | ||||||
2026-09-09 | BBNX | Beta Bionics, Inc. | Hopman Mark | Chief Commercial Officer | S - Sale | $18.46 | -36,870 | 87,157 | -30% | -$680,723 | ||||||
2026-09-10 | KIDS | Orthopediatrics Corp | Pelizzon David R | Dir, 10% | S - Sale | $21.01 | -302,369 | 6,246,148 | -5% | -$6,352,773 | ||||||
2026-09-08 | GIPL | Global Innovative Platforms Inc. | Brown David A B | 10% | P - Purchase | $0.50 | +2,500 | 6,778,112 | 0% | +$1,250 | ||||||
2026-09-08 | ATRC | Atricure, Inc. | Privitera Salvatore | Chief Technical Officer | S - Sale | $55.00 | -3,657 | 147,264 | -2% | -$201,135 | ||||||
| D | 2026-09-08 | RMD | Resmed Inc | Farrell Michael J. | COB, CEO | S - Sale+OE | $222.44 | -4,991 | 468,346 | -1% | -$1,110,191 | |||||
2026-09-04 | SSII | Ss Innovations International, Inc. | Sudhir Srivastava | COB, CEO, 10% | S - Sale | $3.00 | -33,333 | 108,520,928 | 0% | -$99,999 | ||||||
2026-09-08 | KRMD | Koru Medical Systems, Inc. | Kalbermatten Adam R | Chief Commercial Officer | P - Purchase | $3.16 | +32,000 | 394,017 | +9% | +$101,120 | ||||||
2026-09-04 | CTSO | Cytosorbents Corp | Chan Phillip P. | CEO | P - Purchase | $0.35 | +200,000 | 1,944,432 | +11% | +$70,000 | ||||||
2026-09-04 | EMBC | Embecta Corp. | Morris Milton Mayo | Dir | S - Sale | $5.88 | -6,293 | 53,828 | -10% | -$36,971 | ||||||
2026-09-03 | IRMD | Iradimed Corp | Allen Monty K | Dir | S - Sale | $86.41 | -1,419 | 19,581 | -7% | -$122,622 | ||||||
2026-09-03 | TNON | Tenon Medical, Inc. | Hrt Financial LP | 10% | P - Purchase | $3.98 | +1,658 | 1,946 | +576% | +$6,599 | ||||||
2026-09-04 | TNON | Tenon Medical, Inc. | Hrt Financial LP | 10% | S - Sale | $3.70 | -1,506 | 1,946 | -44% | -$5,572 | ||||||
| D | 2026-08-27 | NMTC | Neuroone Medical Technologies Corp | Wambeke David J. | Chief Business Officer | P - Purchase | $2.01 | +33,333 | 199,999 | +20% | +$66,999 | |||||
2026-09-03 | OBIO | Orchestra Biomed Holdings, Inc. | Hochman David P | See Remarks | P - Purchase | $4.79 | +10,000 | 1,516,085 | +1% | +$47,900 | ||||||
| M | 2026-09-02 | HTFL | Heartflow, Inc. | Verghese Vikram | CFO | S - Sale | $49.85 | -33,416 | 221,143 | -13% | -$1,665,796 | |||||
2026-09-03 | BBNX | Beta Bionics, Inc. | Saint Sean | Pres, CEO | S - Sale | $20.08 | -5,641 | 398,429 | -1% | -$113,259 | ||||||
2026-09-02 | KIDS | Orthopediatrics Corp | Squadron Capital LLC | 10% | S - Sale | $23.35 | -22,500 | 6,504,133 | 0% | -$525,375 | ||||||
2026-09-02 | KIDS | Orthopediatrics Corp | Pritzker Jennifer N. | 10% | S - Sale | $23.35 | -22,500 | 6,518,840 | 0% | -$525,375 | ||||||
2026-09-02 | KIDS | Orthopediatrics Corp | Pelizzon David R | Dir, 10% | S - Sale | $23.35 | -22,500 | 6,548,517 | 0% | -$525,375 | ||||||
| M | 2026-09-02 | AORT | Artivion, Inc. | Green Andrew M | SVP, Regulatory, Quality | S - Sale | $27.03 | -8,003 | 51,640 | -13% | -$216,337 | |||||
2026-09-02 | ATRC | Atricure, Inc. | Privitera Salvatore | Chief Technical Officer | S - Sale | $52.50 | -7,763 | 150,921 | -5% | -$407,558 | ||||||
2026-09-02 | RMD | Resmed Inc | Farrell Peter C | Dir | S - Sale | $234.73 | -970 | 51,803 | -2% | -$227,688 | ||||||
| D | 2026-09-01 | SIBN | Si-Bone, Inc. | Dunn Jeffrey W | Dir | S - Sale+OE | $18.91 | -20,000 | 97,130 | -17% | -$378,160 | |||||
2026-09-03 | ICUI | Icu Medical Inc/De | Sanzone Virginia Ruth | VP, GC | S - Sale | $168.69 | -4,856 | 14,604 | -25% | -$819,150 | ||||||
2026-09-01 | LUNG | Pulmonx Corp | French Glendon E. III | Pres, CEO | S - Sale | $2.26 | -41,882 | 2,056,134 | -2% | -$94,653 | ||||||
2026-09-01 | LUNG | Pulmonx Corp | Radhakrishnan Srikanth | Chief Science, Techn. Officer | S - Sale | $2.26 | -14,245 | 316,994 | -4% | -$32,194 | ||||||
2026-09-01 | LUNG | Pulmonx Corp | Lehman David Aaron | GC | S - Sale | $2.26 | -14,334 | 361,827 | -4% | -$32,395 | ||||||
2026-09-01 | LUNG | Pulmonx Corp | Rose Geoffrey Beran | Chief Commercial Officer | S - Sale | $2.26 | -7,879 | 449,832 | -2% | -$17,807 | ||||||
2026-09-02 | BBNX | Beta Bionics, Inc. | Hopman Mark | Chief Commercial Officer | S - Sale | $19.11 | -5,327 | 124,027 | -4% | -$101,815 | ||||||
2026-09-02 | BBNX | Beta Bionics, Inc. | Russell Steven Jon | Chief Medical Officer | S - Sale | $19.11 | -4,221 | 169,628 | -2% | -$80,676 | ||||||
2026-09-02 | BBNX | Beta Bionics, Inc. | Mensinger Mike | Chief Product Officer | S - Sale | $19.11 | -4,375 | 180,040 | -2% | -$83,620 | ||||||
2026-09-02 | BBNX | Beta Bionics, Inc. | Feider Stephen | CFO | S - Sale | $19.11 | -6,675 | 159,378 | -4% | -$127,580 | ||||||
2026-09-02 | BBNX | Beta Bionics, Inc. | Saint Sean | Pres, CEO | S - Sale | $19.11 | -16,867 | 404,070 | -4% | -$322,381 | ||||||
2026-09-01 | TNON | Tenon Medical, Inc. | Hrt Financial LP | 10% | P - Purchase | $4.57 | +1,790 | 1,794 | >999% | +$8,180 | ||||||
2026-09-02 | TNON | Tenon Medical, Inc. | Hrt Financial LP | 10% | S - Sale | $4.53 | -450 | 1,794 | -20% | -$2,039 | ||||||
2026-09-02 | IRTC | Irhythm Holdings, Inc. | Wilson Daniel G. | CFO | S - Sale | $121.83 | -773 | 34,987 | -2% | -$94,175 | ||||||
| M | 2026-08-31 | PLSE | Pulse Biosciences, Inc. | Teplitsky Liane Rae | COO | P - Purchase | $49.37 | +2,025 | 4,095 | +98% | +$99,971 | |||||
2026-09-01 | OBIO | Orchestra Biomed Holdings, Inc. | Sherman Darren | See Remarks | S - Sale | $4.94 | -15,000 | 1,136,402 | -1% | -$74,100 | ||||||
| M | 2019-06-26 | SYK | Stryker Corp | Brainerd Mary K | Dir | P - Purchase | $204.09 | +131 | 7,921 | +2% | +$26,736 | |||||
| M | 2026-08-28 | KIDS | Orthopediatrics Corp | Squadron Capital LLC | 10% | S - Sale | $23.04 | -336,831 | 6,526,633 | -5% | -$7,761,194 | |||||
| M | 2026-08-28 | KIDS | Orthopediatrics Corp | Pritzker Jennifer N. | 10% | S - Sale | $23.04 | -336,831 | 6,541,340 | -5% | -$7,761,194 | |||||
2026-08-28 | GKOS | Glaukos Corp | Navratil Tomas | CHIEF DEVELOPMENT OFFICER | S - Sale | $180.67 | -13,744 | 73,890 | -16% | -$2,483,104 | ||||||
2026-09-01 | ICUI | Icu Medical Inc/De | Bonnell Brian Michael | CFO | S - Sale | $175.00 | -6,381 | 56,062 | -10% | -$1,116,675 | ||||||
| M | 2026-08-28 | KIDS | Orthopediatrics Corp | Pelizzon David R | Dir, 10% | S - Sale | $23.04 | -336,831 | 6,571,017 | -5% | -$7,761,194 | |||||
2026-08-28 | TNON | Tenon Medical, Inc. | Hrt Financial LP | 10% | P - Purchase | $5.58 | +18,357 | 454 | -103% | +$102,458 | ||||||
| M | 2026-08-28 | TNON | Tenon Medical, Inc. | Hrt Financial LP | 10% | S - Sale | $6.91 | -8,299 | 454 | -95% | -$57,334 | |||||
2026-08-31 | ICUI | Icu Medical Inc/De | Bonnell Brian Michael | CFO | S - Sale | $172.79 | -9,307 | 62,443 | -13% | -$1,608,143 | ||||||
2026-08-27 | TNON | Tenon Medical, Inc. | Hrt Financial LP | 10% | S - Sale | $4.96 | -419 | 9,604 | -4% | -$2,078 | ||||||
| M | 2026-08-28 | SRTS | Sensus Healthcare, Inc. | Sachetta Eric | Dir | P - Purchase | $3.48 | +64,841 | 296,877 | +28% | +$225,616 | |||||
| AM | 2026-08-27 | AURX | Nuo Therapeutics, Inc. | Jorden David Emerson | CEO, CFO | P - Purchase | $1.09 | +8,773 | 2,070,000 | 0% | +$9,539 | |||||
| M | 2026-08-26 | PLSE | Pulse Biosciences, Inc. | Teplitsky Liane Rae | COO | P - Purchase | $48.29 | +2,070 | 2,070 | New | +$99,965 | |||||
2026-08-27 | DXCM | Dexcom Inc | Stern Sadie | EVP Chief People, Culture Off | S - Sale | $88.37 | -2,565 | 126,043 | -2% | -$226,669 | ||||||
2026-08-26 | OBIO | Orchestra Biomed Holdings, Inc. | Sherman Darren | See Remarks | P - Purchase | $5.33 | +2,000 | 1,151,402 | 0% | +$10,660 | ||||||
2026-08-26 | SI | Shoulder Innovations, Inc. | Gilde Healthcare Holding B.V. | 10% | S - Sale | $22.60 | -1,196 | 2,185,914 | 0% | -$27,030 | ||||||
| M | 2026-08-26 | SRTS | Sensus Healthcare, Inc. | Sachetta Eric | Dir | P - Purchase | $3.23 | +20,633 | 232,036 | +10% | +$66,682 | |||||
2026-08-25 | UFPT | Ufp Technologies Inc | Kozin Marc D | Dir | S - Sale | $304.50 | -7,000 | 21,112 | -25% | -$2,131,475 | ||||||
2026-08-26 | BDX | Becton Dickinson & Co | Feld Michael | EVP, Chief Revenue Officer | S - Sale | $188.49 | -165 | 19,720 | -1% | -$31,101 | ||||||
2026-08-24 | SIBN | Si-Bone, Inc. | Francis Laura | CEO | S - Sale | $20.12 | -25,972 | 785,391 | -3% | -$522,596 | ||||||
2026-08-24 | SIBN | Si-Bone, Inc. | Maheshwari Anshul | Chief Op, Financial Officer | S - Sale | $20.11 | -11,636 | 223,284 | -5% | -$233,971 | ||||||
2026-08-25 | BSX | Boston Scientific Corp | Morano Susan E | Dir | P - Purchase | $49.22 | +2,040 | 13,784 | +17% | +$100,408 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |